Decamethonium

Decamethonium
Systematic (IUPAC) name
trimethyl-(10-trimethylammoniodecyl)ammonium
Identifiers
CAS Number 156-74-1
ATC code none
PubChem CID 10921
DrugBank DB01245 YesY
ChemSpider 10459 YesY
UNII C1CG1S3T2W YesY
ChEBI CHEBI:41934 YesY
ChEMBL CHEMBL1134 YesY
Chemical data
Formula C16H38N2
Molar mass 258.486 g/mol
  (verify)

Decamethonium (Syncurine) is a depolarizing muscle relaxant or neuromuscular blocking agent,[1] and is used in anesthesia to induce paralysis.

Pharmacology

Decamethonium, which has a short action time, is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor. In the motor endplate, it causes depolarization, preventing further effects to the normal release of acetylcholine from the presynaptic terminal, and therefore preventing the neural stimulus from affecting the muscle. In the process of binding, decamethonium actually activates (depolarizes) the motor endplate - but since the decamethonium itself is not degraded, the membrane remains depolarized and unresponsive to normal acetylcholine release.

Contraindications/limitations

Decamethonium does not produce unconsciousness or anesthesia, and its effects may cause considerable psychological distress while simultaneously making it impossible for a patient to communicate. For these reasons, administration of the drug to a conscious patient is strongly advised against, except in necessary emergency situations.

Decamethonium was used clinically in the UK for many years, but it is now available only for research purposes.

See also

References



This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.